When was Jubilant HollisterStier founded?

Jubilant HollisterStier was founded in 1921.

Where is Jubilant HollisterStier located?

Jubilant HollisterStier is headquartered in Spokane, United States.

Who is the current CEO of Jubilant HollisterStier?

Marcelo Morales of Jubilant HollisterStier. They have also founded 1 company.

How many employees does Jubilant HollisterStier have?

As of Jul 01, 2024, the latest employee count at Jubilant HollisterStier is 336.

Is Jubilant HollisterStier a funded company?

Jubilant HollisterStier is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Jubilant HollisterStier rank among its competitors?

Jubilant HollisterStier ranks 13th amongst 103 active competitors, of which 9 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Avenacy, which secured $26M in Nov, 2024.

Who are the top competitors of Jubilant HollisterStier?

Jubilant HollisterStier's top competitors include Luoxin Pharmaceutical Group, Exela Pharma and ApiJect. Among them, Avenacy secured the most recent funding round in November, 2024.

Jubilant HollisterStier - 2026 Company Profile, Team & Competitors

Jubilant HollisterStier is an unfunded company based in Spokane (United States), founded in 1921. It operates as a CDMO offering sterile and non-sterile manufacturing services. Jubilant HollisterStier has not raised any funding yet. The company has 103 active competitors, including 9 funded and 24 that have exited. Its top competitors include companies like Luoxin Pharmaceutical Group, Exela Pharma and ApiJect.

Company Details

Jubilant HollisterStier provides sterile and non-sterile drug manufacturing services both for clinical and commercial purposes to pharma industries. Their sterile manufacturing services include liquid and lyophilized products in vials and ampoules, ophthalmic and otic solutions, ointments and suspensions in bottles and tubes. Non-sterile manufacturing services include ointments, cream and liquid products in bottles, tubes, jars, suppositories and applicators. They have capabilities to offer their services right from Phase I (for both sterile filling and lyophilization) to commercialization. Their support services include validation support, quality assurance, full-service labs (that also offer outsourcing services), regulatory support, project management and client notification system services. The company has capabilities for development and manufacture of Vaccines, Biological Proteins, Microspheres, Liposomes, Suspensions, WFI/Diluents, and Lyophilized products. Its facilities are approved by FDA, EMEA (Europe), PMDA (Japan) and ANVISA (Brazil).

Website: jublhs.com
Part Of

Key Metrics

Founded Year

1921

Location

Spokane, United States

Stage

Unfunded

Ranked

13^th among 103 active competitors

Employee Count

336 as on Jul 01, 2024

Investment & Acquisitions

Spokane Allergy & Asthma Clinic

Similar Companies

Luoxin Pharmaceutical Group & 117 more

View Jubilant HollisterStier's full profile

Jubilant HollisterStier has not raised any funding rounds yet.

Jubilant HollisterStier's employee count trend

Jubilant HollisterStier has 336 employees as of Jul 24. Here is Jubilant HollisterStier's employee count trend over the years:

Employee count trend for Jubilant HollisterStier

Uncover Jubilant HollisterStier's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Jubilant HollisterStier include Luoxin Pharmaceutical Group, Exela Pharma and ApiJect. Here is the list of Top 10 competitors of Jubilant HollisterStier, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Luoxin Pharmaceutical Group 2006, Linyi (China), Acquired	Developer and manufacturer of pharmaceutical products	$301M	Ennovation Ventures, Yuanchuang Duoying Investment Group ... Read more	58/100
2nd	Exela Pharma 2005, Lenoir (United States), Series B	Manufacturer of sterile injectable pharmaceutical products and CDMO services	$6.67M	Trinity Capital, Presidio Partners & 2 others	58/100
3rd	ApiJect 2015, Stamford (United States), Series D	Manufacturer of medicine injectors	$111M	Jefferies, Royalty Pharma & 2 others	54/100
4th	Gland Pharma 1978, Hyderabad (India), Public	Manufacturer of generic injectable drug	$209M	KKR & 59 others	54/100
5th	Summit Biosciences 2008, Lexington (United States), Acquired	Developer of nasal spray drug products	-	Keyhorse Capital, Mammoth View	53/100
6th	INCOG BioPharma Services 2020, United States, Series C	CDMO focused on manufacturer of injectable drug product	$86.6M	-	53/100
7th	American Regent 1967, Shirley (United States), Unfunded	Pharmaceutical company providing essential medicines and improving patient and animal lives	-	-	50/100
8th	August Bioservices 2017, Nashville (United States), Series B	Provider of diversified research services for clinical solutions	$88.6M	Oak HC/FT, Polaris Partners	48/100
9th	Vetter Pharma 1950, Ravensburg (Germany), Funding Raised	CDMO specializing in aseptically prefilled syringe systems, cartridges and vials.	-	Deutsche Bank, Commerzbank & 1 others	47/100
10th	Avenacy 2023, Schaumburg (United States), Series B	Specialty pharmaceutical company focused on developing and manufacturing critical medications.	$26M	-	45/100
13th	Jubilant HollisterStier 1921, Spokane (United States), Unfunded	CDMO offering sterile and non-sterile manufacturing services	-	-	39/100